Dermatomyositis is an inflammatory disorder involving muscle and skin. Similar to many other autoimmune diseases, environmental factors appear to trigger the onset of disease in some cases. Many drugs have been reported to be associated with dermatomyositis, and rarely infections have been described as potential triggering agents. Here we are describing a case of dermatomyositis that developed after doxycycline and levofloxacin use, who also had recent Epstein-Barr virus infection. Dermatomyositis associated with doxycycline or levofloxacin use has not yet been described in the literature, while reports of dermatomyositis after Epstein-Barr virus infection have been rare and limited to juvenile dermatomyositis or in association with cancer. It is important for clinicians to be aware of this rare association so that the diagnosis and treatment can be exercised promptly.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687046PMC
http://dx.doi.org/10.1016/j.amjms.2020.05.011DOI Listing

Publication Analysis

Top Keywords

epstein-barr virus
12
virus infection
12
dermatomyositis developed
8
doxycycline levofloxacin
8
dermatomyositis
7
developed exposure
4
exposure epstein-barr
4
infection antibiotics
4
antibiotics dermatomyositis
4
dermatomyositis inflammatory
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!